Create a free Cannabis Equipment News account to continue

Patients Should Be Screened for Cannabis Use Before Receiving Anesthesia

The guidelines were developed in response to the increased use of cannabis during the past 20 years.

I Stock 469782812
iStock

All patients undergoing procedures requiring anesthesia should be asked about cannabis use, according to guidelines released by the American Society of Regional Anesthesia and Pain Medicine (ASRA Pain Medicine). The first U.S. guidelines on cannabis use in relation to surgery also notes regular use may worsen pain and nausea after surgery and increase the need for opioids.

The guidelines were developed in response to the increased use of cannabis during the past 20 years and concerns that it potentially can interact with anesthesia and lead to complications. About 10% of Americans use cannabis monthly, and it is the most commonly used psychotropic substance after alcohol, according to the U.S. Substance Abuse and Mental Health Services Administration.

“Before surgery, anesthesiologists should ask patients if they use cannabis – whether medicinally or recreationally – and be prepared to possibly change the anesthesia plan or delay the procedure in certain situations,” said Samer Narouze, MD, PhD, senior author and ASRA Pain Medicine president. “They also need to counsel patients about the possible risks and effects of cannabis. For example, even though some people use cannabis therapeutically to help relieve pain, studies have shown regular users may have more pain and nausea after surgery, not less, and may need more medications, including opioids, to manage the discomfort. We hope the guidelines will serve as roadmap to help better care for patients who use cannabis and need surgery.”

The guidelines recommend anesthesiologists screen all patients for cannabis use, including asking about the type of cannabis product used, how it was used (eg, smoked, ingested), amount used, how recently it was used and frequency of use.

The guidelines are based on an extensive literature review and experiences from the organization’s “Perioperative Use of Cannabis and Cannabinoids Guidelines Committee,” composed of 13 experts, including anesthesiologists, chronic pain physicians and a patient advocate. The committee addressed nine questions and made 21 recommendations using a modified Delphi consensus method with ­>75% agreement required for recommendation.­ Recommendation grades were based on the United States Preventive Services Task Force (USPSTF) process that assigns a letter (an A, B, C, or D grade or an I for insufficient) based on the strength of the evidence and the balance of benefits and harms. All 21 recommendations achieved full consensus.

This is the first U.S.-based guideline on perioperative (before, during and after surgery) management of cannabis, according to lead researcher Shalini Shah, MD, vice chair of anesthesiology at the University of California at Irvine School of Medicine. The guidelines cover preoperative, intraoperative and immediate postoperative care considerations. The American Society of Anesthesiologists reviewed the guidelines and is in agreement with their recommendations and affirms their value for anesthesiologists and surgeons. They are not intended to replace clinical judgement but rather promote improved patient communication and possibly improved outcomes.

Recommendations receiving an A grade support (the highest level of evidence) include: 1) screening all patients before surgery, 2) postponing elective surgery in patients who have altered mental status or impaired decision-making capacity at the time of surgery, 3) counseling frequent, heavy users on the potentially negative effects of cannabis use on postoperative pain control and 4) counseling pregnant patients on the risks of cannabis use to the unborn child.

More in News